The development of effective anti-androgen therapies for prostate cancer is a major scientific advance.
Most men with prostate cancer won’t die from the disease.
An old military tactic, widely used in Roman and medieval times, is now being put to good use in cancer research.
In an ongoing clinical trial, researchers are using gold nanoparticles to target prostate cancer cells. So far, the results are promising, and side effects are relatively minimal.
WebMD with Robin Roberts has a video The Cutting Edge of Cancer, Search and Destroy: Targeted Cancer Therapy...